republic-os/legislation/us/states/in/2026/sb-91.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Syringe exchange program.	Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.	us/states/in	Indiana General Assembly	2026	SB 91	Indiana SB 91 (2026)	bill	ADDICTION SERVICES; Illicit Drugs Prescription Drugs Substances and Alcohol AGENCIES; Department of Health (IDOH) CRIMINAL LAW AND PROCEDURE; Illicit Drugs Substances and Alcohol Offenses HEALTH; Communicable Diseases Infectious Diseases HEALTH; Generally HEALTH; Prescription Drugs and Medications	enacted	Brett Clark Ed Charbonneau Edward Clere Michael Crider	6	33	3	2025-12-09	2026-03-10	openstates	ocd-bill/e96e7996-7eb4-46e8-91ee-4fbeed170dee	https://api.iga.in.gov/2026/bills/sb0091	6de8898ea339833460d73349dc49026d1c65bc96f7ac3987e0acb42a12f6fbde	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-in

Indiana SB 91 (2026) — Syringe exchange program.

Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Engrossed Senate Bill (H) (committee substitute) — source
2. Engrossed Senate Bill (S) (committee substitute) — source
3. Enrolled Senate Bill (S) (committee substitute) — source
4. Introduced Senate Bill (S) (committee substitute) — source
5. Senate Bill (H) (committee substitute) — source
6. Senate Bill (S) (committee substitute) — source

Votes

• SB 91 - Crider - 3rd Reading — 33–13 (pass) · upper
• SB 91 - Clere - 3rd Reading — 70–22 (pass) · lower
• SB 91 - Crider — 38–10 (pass) · upper

Sponsors

• Brett Clark — primary (person)
• Ed Charbonneau — primary (person)
• Edward Clere — primary (person)
• Michael Crider — primary (person)
• Alex Zimmerman — cosponsor (person)
• Ethan Lawson — cosponsor (person)
• Kyle Walker — coauthor (person)
• La Keisha Jackson — coauthor (person)
• Lonnie Randolph — coauthor (person)
• Mike Bohacek — coauthor (person)
• Rodney Pol — coauthor (person)
• Shelli Yoder — coauthor (person)
• Victoria Garcia Wilburn — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-12-09 First reading: referred to Committee on Health and Provider Services reading-1, referral-committee
• 2025-12-09 Authored by Senator Crider
• 2026-01-08 Senator Yoder added as coauthor
• 2026-01-08 Senator Clark added as third author
• 2026-01-08 Committee report: do pass, adopted committee-passage
• 2026-01-08 Senator Charbonneau added as second author
• 2026-01-12 Senator Walker K added as coauthor
• 2026-01-13 Senators Bohacek, Jackson L added as coauthors
• 2026-01-20 Senator Randolph added as coauthor
• 2026-01-26 Amendment #2 (Crider) prevailed; voice vote amendment-passage
• 2026-01-26 Second reading: amended, ordered engrossed reading-2
• 2026-01-27 Senator Pol added as coauthor
• 2026-01-27 House sponsor: Representative Clere
• 2026-01-27 Third reading: passed; Roll Call 93: yeas 33, nays 13 passage, reading-3, reading-3
• 2026-01-27 Cosponsors: Representatives Lawson, Goss-Reaves
• 2026-01-28 Representative Goss-Reaves removed as cosponsor
• 2026-01-28 Referred to the House referral
• 2026-01-29 First reading: referred to Committee on Public Health reading-1, referral-committee
• 2026-02-10 Committee report: amend do pass, adopted committee-passage
• 2026-02-17 Amendment #12 (Ireland) prevailed; voice vote amendment-passage
• 2026-02-17 Amendment #14 (Clere) prevailed; voice vote amendment-passage
• 2026-02-17 Representatives Zimmerman, Garcia Wilburn added as cosponsors
• 2026-02-17 Second reading: amended, ordered engrossed reading-2
• 2026-02-17 Amendment #11 (Mayfield) prevailed; voice vote amendment-passage
• 2026-02-18 Third reading: passed; Roll Call 271: yeas 70, nays 22 passage, reading-3, reading-3
• 2026-02-19 Motion to concur filed filing
• 2026-02-19 Returned to the Senate with amendments receipt
• 2026-02-25 Senate concurred with House amendments; Roll Call 273: yeas 38, nays 10
• 2026-02-27 Signed by the President of the Senate passage
• 2026-02-27 Signed by the Speaker passage
• 2026-03-10 Bill Became Law on 8th Day Without Signature
• 2026-02-27 Signed by the President Pro Tempore passage
• 2026-03-10 Public Law 144 became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/e96e7996-7eb4-46e8-91ee-4fbeed170dee. Confidence: reported (aggregated from official Indiana legislature records).